Compare Ashmore Asset Management Indonesia Tbk (AMOR) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Ashmore Asset Management Indonesia Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Ashmore Asset Management Indonesia Tbk trades at Rp322 (market cap 715.56B, 25.9K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp152 (market cap 556.95B, 60.83M 24h volume). The key difference: Ashmore Asset Management Indonesia Tbk is the larger of the two by market cap, and UBC Medical Indonesia Tbk. is more actively traded (60.83M versus 25.9K). Which is the better fit depends on your goals.
| AMOR | LABS | |
|---|---|---|
Market Cap | 715.56B | 556.95B |
Volume | 25.9K | 60.83M |
Lot | 259 | 608.34K |
Turnover | 8.31M | 10.26B |
Average Price | 320.73 | 168.64 |
Value | 8.31M | 10.26B |
Indicative Equilibrium Price | 322 | 152 |
Indicative Equilibrium Volume | 1 | 4.52K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ashmore Asset Management Indonesia Tbk
PT Ashmore Asset Management Indonesia Tbk (the Company) initially established under the name of PT Buana Megah Abadi, is an Indonesian domiciled Company. The Company was established based on notary deed No. 250 dated 29 January 2010 of Doctor Irawan Soerodjo, SH.MSi.
Read more on AMOR →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
